Last reviewed · How we verify
NCT05147597
Turkish Validity and Reliability of SGRQ-I
trial testing Questionnaire in IPF in 180 participants. Currently enrolling.
1 January 2026
Quick facts
| Lead sponsor | Saglik Bilimleri Universitesi |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 180 |
| Start date | 9 January 2022 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 January 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Questionnaire
Conditions studied
- IPF — all drugs for IPF →
Sponsor
Saglik Bilimleri Universitesi — full company profile →
Who can join
18 and older, any sex, with IPF. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Saint George Respiratory Questionnaire (SGRQ) questionnaire is a frequently used questionnaire in the respiratory patient group, and the Turkish version of this questionnaire, which was created for use in idiopathic pulmonary fibrosis patients, is not available. There is no commonly used quality of life questionnaire in patients with idiopathic pulmonary fibrosis. The aim of the study is to translate and validate the SGRQ idiopathic pulmonary fibrosis version of questionnaire into Turkish.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05147597
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire
Trials testing the same drug.
- NCT04466371 — Perceptions of Undergraduate Students and Teaching Staff on Online Teaching · suspended
- NCT07089953 — Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomiz · NA · not yet recruiting
- NCT07418775 — Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma · not yet recruiting
- NCT07226804 — Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules · not yet recruiting
- NCT07532954 — The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support · recruiting
Other recruiting trials for IPF
Currently open trials in the same condition.
- NCT06747923 — SB17170 Phase 2 Trial in IPF Patients · Phase 2 · recruiting
- NCT07139925 — Assessment of Self-Care in Patients With Idiopathic Pulmonary Fibrosis (IPF) · active not recruiting
- NCT06644144 — P4O2 ILD Extension · recruiting
- NCT06714812 — Diarrheal Adverse Events in Caucasian Patients With Idiopathic Pulmonary Fibrosis Undergoing Treatment With Nintedanib · active not recruiting
- NCT05570058 — Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis · Phase 2 · active not recruiting
Other Saglik Bilimleri Universitesi trials
Trials by the same sponsor.
- NCT07499986 — Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery · NA · not yet recruiting
- NCT07516340 — Gamification-Based Peer Education in Nursing Students: Effects on Sexual Health Literacy and Attitudes · NA · not yet recruiting
- NCT07520435 — Short-Term Mindfulness Intervention for Anxiety and Maternal Attachment in NICU Mothers · NA · not yet recruiting
- NCT07528001 — Hypno-Breastfeeding Education and Postpartum Outcomes · NA · not yet recruiting
- NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05147597 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saglik Bilimleri Universitesi
- Last refreshed: 1 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05147597.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing